Bioventus Inc. (BVS) Insider Trading Activity

NASDAQ$11.675+0.73 (6.67%)
Market Cap
$747.6M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
458 of 849
Rank in Industry
59 of 107

BVS Insider Trading Activity

BVS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$312,352
3
100

Related Transactions

NOHRA GUY Pdirector
0
$0
1
$75,658
$-75,658
McMurry-Heath Michelledirector
0
$0
2
$236,694
$-236,694

About Bioventus Inc.

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a …

Insider Activity of Bioventus Inc.

Over the last 12 months, insiders at Bioventus Inc. have bought $0 and sold $312,352 worth of Bioventus Inc. stock.

On average, over the past 5 years, insiders at Bioventus Inc. have bought $4.05M and sold $568,065 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 25,500 shares for transaction amount of $217,966 was made by Bartholdson John A. () on 2024‑08‑19.

List of Insider Buy and Sell Transactions, Bioventus Inc.

2026-03-11SaleMcMurry-Heath Michelledirector
12,000
0.0177%
$8.79
$105,439
+30.00%
2025-12-04SaleNOHRA GUY Pdirector
10,000
0.0148%
$7.57
$75,658
+27.69%
2025-11-07SaleMcMurry-Heath Michelledirector
17,701
0.03%
$7.42
$131,255
+24.56%
2025-04-11SaleSingleton Mark LeonardSVP & CFO
3,875
0.0054%
$7.57
$29,334
-2.67%
2025-04-11SaleD'Adamio AnthonySVP & General Counsel
2,958
0.0041%
$7.57
$22,392
-2.67%
2025-04-11SaleCHURCH KATRINA JSVP & Chief Compliance Officer
1,283
0.0018%
$7.57
$9,712
-2.67%
2025-03-24SaleSingleton Mark LeonardSVP & CFO
5,479
0.0083%
$9.79
$53,639
-25.00%
2025-03-17SaleD'Adamio AnthonySVP & General Counsel
2,615
0.0039%
$9.75
$25,496
-25.61%
2025-03-17SaleCHURCH KATRINA JSVP & Chief Compliance Officer
1,018
0.0015%
$9.75
$9,926
-25.61%
2025-02-18SaleSingleton Mark LeonardSVP & CFO
6,498
0.0097%
$10.19
$66,215
-29.84%
2025-02-18SaleD'Adamio AnthonySVP & General Counsel
4,380
0.0066%
$10.19
$44,632
-29.84%
2025-02-18SaleCHURCH KATRINA JSVP & Chief Compliance Officer
1,537
0.0023%
$10.19
$15,662
-29.84%
2025-01-13SaleClaypoole Robert EPresident and CEO
28,786
0.0439%
$9.10
$261,953
-20.41%
2024-12-23SaleD'Adamio AnthonySVP & General Counsel
5,848
0.0089%
$10.53
$61,579
-31.46%
2024-12-23SaleSingleton Mark LeonardSVP & CFO
10,733
0.0163%
$10.53
$113,018
-31.46%
2024-12-23SaleCHURCH KATRINA JSVP & Chief Compliance Officer
2,535
0.0038%
$10.53
$26,694
-31.46%
2024-08-19PurchaseBartholdson John A.
25,500
0.0418%
$8.55
$217,966
+22.13%
2024-08-16PurchaseBartholdson John A.
80,000
0.1383%
$8.55
$683,736
+12.90%
2024-06-21SaleD'Adamio AnthonySVP & General Counsel
5,904
0.0079%
$5.57
$32,885
+72.84%
2024-06-21SaleSingleton Mark LeonardSVP & CFO
9,219
0.0123%
$5.57
$51,350
+72.84%
Total: 72
*Gray background shows transactions not older than one year

Insider Historical Profitability

17.03%
Bartholdson John A.
6939357
10.1594%
$75.95M110
+34.62%
Juniper Investment Company, LLC10 percent owner
6833857
10.0049%
$74.8M30
+4.52%
HAWKINS WILLIAM Adirector
184310
0.2698%
$2.02M20
+54.46%
Pavesio AlessandraSVP & Chief Science Officer
148309
0.2171%
$1.62M12
<0.0001%
Bihl Anthony P IIIInterim CEO
138290
0.2025%
$1.51M20
+37.73%
D'Adamio AnthonySVP & General Counsel
131416
0.1924%
$1.44M111
<0.0001%
Nosenzo JohnFmr. Chief Commercial Officer
87148
0.1276%
$953,834.8615
<0.0001%
CHURCH KATRINA JSVP & Chief Compliance Officer
55557
0.0813%
$608,071.37114
<0.0001%
Anglum Gregory O.SVP & CFO
55013
0.0805%
$602,117.2911
<0.0001%
Reali Kenneth MichaelChief Executive Officer
30085
0.044%
$329,280.3321
<0.0001%
*Gray background shows insiders who have made transactions during last year

BVS Institutional Investors: Active Positions

Increased Positions87+67.97%4M+9.21%
Decreased Positions52-40.63%2M-4.04%
New Positions27New2MNew
Sold Out Positions14Sold Out394,197Sold Out
Total Postitions163+27.34%51M+5.17%

BVS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Essex Woodlands Management, Inc.$93,884.0019.43%13.02M00%2025-09-30
Juniper Investment Company, Llc$50,033.0010.36%6.94M00%2025-09-30
Nantahala Capital Management, Llc$41,895.008.67%5.81M+529,820+10.03%2025-09-30
Blackrock, Inc.$22,127.004.58%3.07M-67,721-2.16%2025-09-30
Vanguard Group Inc$21,088.004.37%2.92M+122,749+4.38%2025-09-30
Royce & Associates Lp$9,106.001.89%1.26M+170,900+15.65%2025-09-30
Geode Capital Management, Llc$7,937.001.64%1.1M+45,947+4.36%2025-09-30
American Century Companies Inc$7,867.001.63%1.09M-32,953-2.93%2025-09-30
Kent Lake Pr Llc$7,211.001.49%1M+650,164+185.74%2025-09-30
State Street Corp$6,319.001.31%876,434-7,662-0.87%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.